Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
853 19 |
Ultima descărcare din IBN: 2022-10-26 08:58 |
Căutarea după subiecte similare conform CZU |
615.225.2.035.1 (1) |
Medicamentele potrivit acţiunii lor principale (395) |
SM ISO690:2012 GHICAVÎI, Victor, BACHINSKY, N.G., PODGURSKY, L. A., ŢURCAN, Lucia, CHIANU, Marin. Selection of antihypertensive drugs from the perspective of clinical pharmacology. In: Moldovan Medical Journal, 2018, nr. 1(61), pp. 18-23. ISSN 2537-6373. DOI: https://doi.org/10.5281/zenodo.1186184 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Moldovan Medical Journal | ||||||
Numărul 1(61) / 2018 / ISSN 2537-6373 /ISSNe 2537-6381 | ||||||
|
||||||
DOI:https://doi.org/10.5281/zenodo.1186184 | ||||||
CZU: 615.225.2.035.1 | ||||||
Pag. 18-23 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background: The rational use of medicines remains one of the most important directions of public health, especially in socio-medical diseases, including arterial hypertension. Material and methods: The study involved 28 cardiologists and 84 internists who, based on a set of questionnaires, expressed their opinion on ambulatory treatment of patients with arterial hypertension. Also 21 internists, 6 cardiologists and 6 obstetrician-gynecologists expressed their opinion on treatment of pregnancy-induced hypertension. Results: Cardiologists and internists recommended angiotensin-converting-enzyme inhibitors (ACE inhibitors) in 28% of cases, diuretics – in 23% of cases, beta-blockers (BB) – in 20, 4% of cases, calcium channel blockers (CCB) – in 13.7% of cases, angiotensin receptor blockers (ARB) – in 13.6% of cases for ambulatory treatment of patients with arterial hypertension. The antihypertensive drugs from other pharmacological groups (with central action, alpha-blockers, arteriodilators, sympatholytics, etc.) were prescribed in only 1.3% of patients. On treatment of hypertension in pregnancy showed that all physicians – 100% recommended as first-line agent for treatment of hypertension during pregnancy centrally acting antihypertensive drug Methyldopa. For second-line treatment they recommended CCB – in 36.36% of cases, alpha-adrenoblockers – in 24.24% of cases, BB – in 21.21% of cases, diuretics – in 12.12% of cases and 3% for ACE inhibitors and ARB. For treatment pre-eclampsia and eclampsia seizures in 84.85% of cases is recommended Magnesium sulfate and 15.15% mention labetalol, hydralazine and sodium nitroprusside. Conclusions: ACE inhibitors, diuretics, BAB, CCB and ARB have been first-line drugs in the arterial hypertension (AHT) treatment. For treatment of pregnancy-induced hypertension physicians recommended centrally acting antihypertensive drug Methyldopa. For second-line treatment they recommended calcium channel blockers (CCB), alpha-adrenoblockers, beta-blockers (BB) and diuretics. As third-choice in treatment of severe hypertension in preeclampsia are selected direct vasodilators as hydralazine, labetalol, sodium nitroprusside, and the most widely used in preeclampsia and eclampsia remains magnesium sulfate. |
||||||
Cuvinte-cheie arterial hypertension, antihypertensive drugs, angiotensin-converting-enzyme inhibitors |
||||||
|
Google Scholar Export
<meta name="citation_title" content="Selection of antihypertensive drugs from the perspective of clinical pharmacology"> <meta name="citation_author" content="Ghicavîi Victor"> <meta name="citation_author" content="Bachinsky N.G."> <meta name="citation_author" content="Podgursky L. A."> <meta name="citation_author" content="Ţurcan Lucia"> <meta name="citation_author" content="Chianu Marin"> <meta name="citation_publication_date" content="2018/03/30"> <meta name="citation_journal_title" content="Moldovan Medical Journal"> <meta name="citation_volume" content="61"> <meta name="citation_issue" content="1"> <meta name="citation_firstpage" content="18"> <meta name="citation_lastpage" content="23"> <meta name="citation_pdf_url" content="https://ibn.idsi.md/sites/default/files/imag_file/Selection%20of%20antihypertensive%20drugs%20from%20the%20perspective%20of%20clinical%20pharmacology.pdf">